| Market Cap | ₹583Cr |
| ROE | 10.38% |
| P/E Ratio(TTM) | 22.32 |
| EPS(TTM) | 14.95 |
| P/B Ratio | 2.20 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.07 |
| Book Value | 151.97 |
| Debt to Equity | 0.31 |
| Face Value | 10 |
| Parent Organisation | Kilitch Drugs (india) Limited. |
| Managing Director | Mukund Mehta |
| Founded | 1992 |
| NSE Symbol | KILITCH |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.10 | ||
| Ajanta Pharma | NA (0.00%) | 33.65 | ||
| Gland Pharma | NA (0.00%) | 34.84 | ||
| Eris Lifesciences | NA (0.00%) | 47.73 |